A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

Investigational New Drugs

Volumn 27, Issue 3, 2009, Pages 269-274

  Kim, Sun Young ^a   Hong, Yong Sang ^a   Kim, Byung Chang ^a   Park, Ji Won ^a   Choi, Hyo Seong ^a   Jeong, Seung Yong ^a   Kim, Dae Yong ^a   Hong, Chang Won ^a   Sohn, Dae Kyung ^a   Jung, Kyung Hae ^a  

^a National Cancer Center   (South Korea)

Author keywords

Colorectal cancer; Irinotecan; Oxaliplatxin; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; FLUOROPYRIMIDINE; IRINOTECAN; LOPERAMIDE; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; ANEMIA; ANOREXIA; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE CONTROL; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPERBILIRUBINEMIA; INFECTION; LEUKOPENIA; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECTUM; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; OXONIC ACID; TEGAFUR; TREATMENT OUTCOME;

EID: 64649100626     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-008-9177-5     Document Type: Article

References (24)

1. JA Meyerhardt RJ Mayer 2005 Systemic therapy for colorectal cancer N Engl J Med 352 476 487
2. RG Azrak S Cao HK Slocum 2004 Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts Clin Cancer Res 10 1121 1129
3. C Barone M Landriscina M Quirino 2007 Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial Br J Cancer 96 21 28
4. E Raymond S Faivre S Chaney 2002 Cellular and molecular pharmacology of oxaliplatin Mol Cancer Ther 1 227 235
5. KH Yeh AL Cheng JP Wan 2004 Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells Anticancer Drugs 15 371 376
6. N Zeghari-Squalli E Raymond E Cvitkovic 1999 Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin Clin Cancer Res 5 1189 1196
7. A Falcone G Masi G Allegrini 2002 Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer J Clin Oncol 20 4006 4014
8. Mini E, Nobili S, Del Buono S, et al (2004) Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (pts) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT. ASCO Meeting Abstracts 22:3751-
9. Park SR, Hong YS, Park YI, et al (2008) A phase I study of S-1 combined with irinotecan and oxaliplatin in metastatic colorectal or gastric carcinoma. ASCO Meeting Abstracts
10. D Cunningham Y Humblet S Siena 2004 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337 345
11. C Garufi E Bria B Vanni 2003 A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients Br J Cancer 89 1870 1875
12. Levi F, Zidani R, Coudert B, et al (2001) Chronomodulated irinotecan (I)-Fluorouracil (F)-Leucovorin (L)-Oxaliplatin(O) (CHRONO IFLO) as salvage therapy in patients with heavily pretreated metastatic colorectal cancer (MCC). ASCO Meeting Abstracts
13. A Falcone S Ricci I Brunetti 2007 Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol 25 1670 1676
14. E Bajetta L Celio E Ferrario 2007 Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer Ann Oncol 18 1810 1816
15. J Souglakos N Androulakis K Syrigos 2006 FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG) Br J Cancer 94 798 805
16. M Malet-Martino R Martino 2002 Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review Oncologist 7 288 323
17. E Sasaki K Tominaga H Kuwamura 2007 Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism J Gastroenterol 42 816 822
18. T Shirasaka K Nakano T Takechi 1996 Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 2602 2606
19. A Goto Y Yamada H Yasui 2006 Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer Ann Oncol 17 968 973
20. Y Yamada M Tahara T Miya 2008 Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer Br J Cancer 98 1034 1038
21. QS Chu LA Hammond G Schwartz 2004 Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies Clin Cancer Res 10 4913 4921
22. HC Jeung SY Rha BC Cho 2006 A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens Br J Cancer 95 1637 1641
23. HX Chen M Mooney M Boron 2006 Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301 J Clin Oncol 24 3354 3360
24. H Au C Karapetis D Jonker 2007 Quality of life in patients with advanced colorectal cancer treated with cetuximab: results of the NCIC CTG and AGITG CO.17 trial J Clin Oncol 25 4002